An innovative artificial intelligence model, VaxSeer, has demonstrated superior accuracy in predicting flu strains for vaccine development, surpassing the World Health Organization (WHO)'s traditional methods. By leveraging genomic data, VaxSeer promises to accelerate vaccine selection, significantly enhancing global vaccination campaign efficacy.